Irrational fixed dose combinations of psychotropic drugs in India: Cause of concern.
- Published in:
- Indian Journal of Pharmacology, 2016, v. 48, n. 4, p. 468, doi. 10.4103/0253-7613.186192
- By:
- Publication type:
- Article
Works matching DE "CENTRAL Drugs Standard Control Organization"
Results: 27
1
2
Regulatory changes in conduct of clinical trials: A need for review.
- Published in:
- 2013
- By:
- Publication type:
- Editorial
3
A revolution in the making.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
4
Febuxostat, a Non-Purine Selective Xanthine Oxidase Inhibitor in The Management of Hyperuricemia and Chronic Gout: A Systematic Review.
- Published in:
- Journal of Advanced Scientific Research, 2012, v. 3, n. 2, p. 3
- By:
- Publication type:
- Article
5
Indian Regulatory Update: January-December 2017.
- Published in:
- Perspectives in Clinical Research, 2018, v. 9, n. 1, p. 48, doi. 10.4103/picr.PICR_176_17
- By:
- Publication type:
- Article
6
Past, Present and Future of Pharmacovigilance in India.
- Published in:
- Systematic Reviews in Pharmacy, 2011, v. 2, n. 1, p. 55, doi. 10.4103/0975-8453.83440
- By:
- Publication type:
- Article
7
Adverse Drug Reactions and their Impact on Quality of Life in Patients on Antipsychotic Therapy at a Tertiary Care Center in Delhi.
- Published in:
- Indian Journal of Psychological Medicine, 2017, v. 39, n. 3, p. 283, doi. 10.4103/0253-7176.207332
- By:
- Publication type:
- Article
8
Clinical Trial Regulations in India: Progress and Challenges Arising from Recent Amendments to Schedule Y of the Drugs and Cosmetics (D&C) Act 1940 (D&C Rules 1945).
- Published in:
- Pharmaceutical Medicine, 2016, v. 30, n. 1, p. 1, doi. 10.1007/s40290-015-0127-1
- By:
- Publication type:
- Article
9
Recent Changes to Clinical Trial Regulation in India: Focus on Serious Adverse Events, Compensation and Registration of Ethics Committees.
- Published in:
- Pharmaceutical Medicine, 2013, v. 27, n. 5, p. 283, doi. 10.1007/s40290-013-0032-4
- By:
- Publication type:
- Article
10
Current Scenario of Spurious and Substandard Medicines in India: A Systematic Review.
- Published in:
- Indian Journal of Pharmaceutical Sciences, 2015, v. 77, n. 1, p. 2, doi. 10.4103/0250-474X.151550
- By:
- Publication type:
- Article
11
India's top drug regulator.
- Published in:
- Nature Medicine, 2014, v. 20, n. 8, p. 802, doi. 10.1038/nm0814-802
- By:
- Publication type:
- Article
12
Failure of Indian whistleblower scheme points to deeper woes.
- Published in:
- Nature Medicine, 2010, v. 16, n. 4, p. 364, doi. 10.1038/nm0410-364a
- By:
- Publication type:
- Article
13
Elderly patients' participation in clinical trials.
- Published in:
- Perspectives in Clinical Research, 2015, v. 6, n. 4, p. 184, doi. 10.4103/2229-3485.167099
- By:
- Publication type:
- Article
14
Indian Regulatory Update: January-March 2015.
- Published in:
- Perspectives in Clinical Research, 2015, v. 6, n. 2, p. 118, doi. 10.4103/2229-3485.154018
- By:
- Publication type:
- Article
15
Indian Regulatory Update: June-August 2014.
- Published in:
- Perspectives in Clinical Research, 2014, v. 5, n. 4, p. 195, doi. 10.4103/2229-3485.140568
- By:
- Publication type:
- Article
16
Indian Regulatory Update: September-November 2013.
- Published in:
- Perspectives in Clinical Research, 2014, v. 5, n. 1, p. 45, doi. 10.4103/2229-3485.124575
- By:
- Publication type:
- Article
17
Shaping future regulatory enterprise.
- Published in:
- 2012
- By:
- Publication type:
- Editorial
18
Adverse drug reactions due to ophthalmic drugs: Reporting system in India.
- Published in:
- 2016
- By:
- Publication type:
- Letter
19
Eyes on New Product Development.
- Published in:
- Journal of Ocular Pharmacology & Therapeutics, 2013, v. 29, n. 4, p. 379, doi. 10.1089/jop.2013.1506
- By:
- Publication type:
- Article
20
Clinical trials in India: At uncertain crossroads?
- Published in:
- 2014
- By:
- Publication type:
- Editorial
21
Ethics of expert opinion and the observations of the department-related parliamentary standing committee on the CDSCO.
- Published in:
- 2012
- By:
- Publication type:
- Editorial
22
Need to change present regulatory framework for blood banks in India.
- Published in:
- 2011
- By:
- Publication type:
- Editorial
23
Maternal near-miss reviews: lessons from a pilot programme in India.
- Published in:
- BJOG: An International Journal of Obstetrics & Gynaecology, 2014, v. 121, p. 105, doi. 10.1111/1471-0528.12942
- By:
- Publication type:
- Article
24
Regulatory developments in the conduct of clinical trials in India.
- Published in:
- 2016
- By:
- Publication type:
- Opinion
25
Regulatory developments in the conduct of clinical trials in India.
- Published in:
- Global Health, Epidemiology & Genomics, 2016, v. 1, p. 1, doi. 10.1017/gheg.2015.5
- By:
- Publication type:
- Article
26
Regulatory developments in the conduct of clinical trials in India.
- Published in:
- Global Health, Epidemiology & Genomics, 2016, v. 1, p. 1, doi. 10.1017/gheg.2015.5
- By:
- Publication type:
- Article
27
Are trial participants adequately safeguarded by the ethics committees--the Indian scenario?
- Published in:
- Frontiers in Pharmacology, 2014, v. 5, p. 1, doi. 10.3389/fphar.2014.00143
- By:
- Publication type:
- Article